These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 32033571)

  • 1. HIV-1 subtype C predicted co-receptor tropism in Africa: an individual sequence level meta-analysis.
    Matume ND; Tebit DM; Bessong PO
    AIDS Res Ther; 2020 Feb; 17(1):5. PubMed ID: 32033571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation sequencing reveals a high frequency of CXCR4 utilizing viruses in HIV-1 chronically infected drug experienced individuals in South Africa.
    Matume ND; Tebit DM; Gray LR; Hammarskjold ML; Rekosh D; Bessong PO
    J Clin Virol; 2018 Jun; 103():81-87. PubMed ID: 29661652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep-Sequencing Analysis of the Dynamics of HIV-1 Quasiespecies in Naive Patients during a Short Exposure to Maraviroc.
    Cascajero A; Rastrojo A; Díez-Fuertes F; Hernández-Novoa B; Aguado B; Moreno S; Alcami J; Pérez-Olmeda M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 coreceptor tropism in India: increasing proportion of X4-tropism in subtype C strains over two decades.
    Gupta S; Neogi U; Srinivasa H; Banerjea AC; Shet A
    J Acquir Immune Defic Syndr; 2014 Apr; 65(4):397-404. PubMed ID: 24189148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 tropism determination using a phenotypic Env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRF01_AE and CRF02_AG [corrected].
    Mulinge M; Lemaire M; Servais JY; Rybicki A; Struck D; da Silva ES; Verhofstede C; Lie Y; Seguin-Devaux C; Schmit JC; Bercoff DP
    PLoS One; 2013; 8(5):e60566. PubMed ID: 23667426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coreceptor Tropism and Maraviroc Sensitivity of Clonally Derived Ethiopian HIV-1C Strains Using an in-house Phenotypic Assay and Commonly Used Genotypic Methods.
    Kalu AW; Telele NF; Aralaguppe SG; Gebre-Selassie S; Fekade D; Marrone G; Sonnerborg A
    Curr HIV Res; 2018; 16(2):113-120. PubMed ID: 29766813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selected amino acid mutations in HIV-1 B subtype gp41 are associated with specific gp120v₃ signatures in the regulation of co-receptor usage.
    Dimonte S; Mercurio F; Svicher V; D'Arrigo R; Perno CF; Ceccherini-Silberstein F
    Retrovirology; 2011 May; 8():33. PubMed ID: 21569409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine Coreceptor Usage Among HIV-1 Drug-Naive Patients Residing in the Rural Eastern Cape, South Africa.
    Digban TO; Iweriebor BC; Nwodo UU; Okoh AI; Obi LC
    AIDS Res Hum Retroviruses; 2020 Aug; 36(8):688-696. PubMed ID: 32466656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predominance of CXCR4 tropism in HIV-1 CRF14_BG strains from newly diagnosed infections.
    Pérez-Álvarez L; Delgado E; Vega Y; Montero V; Cuevas T; Fernández-García A; García-Riart B; Pérez-Castro S; Rodríguez-Real R; López-Álvarez MJ; Fernández-Rodríguez R; Lezaun MJ; Ordóñez P; Ramos C; Bereciartua E; Calleja S; Sánchez-García AM; Thomson MM
    J Antimicrob Chemother; 2014 Jan; 69(1):246-53. PubMed ID: 23900735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.
    Svicher V; Balestra E; Cento V; Sarmati L; Dori L; Vandenbroucke I; D'Arrigo R; Buonomini AR; Van Marck H; Surdo M; Saccomandi P; Mostmans W; Aerssens J; Aquaro S; Stuyver LJ; Andreoni M; Ceccherini-Silberstein F; Perno CF
    Antiviral Res; 2011 Apr; 90(1):42-53. PubMed ID: 21349294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral Tropism in Human Immunodeficiency Virus Type 1-Infected Children and Adolescents in Thailand.
    Arayapong N; Pasomsub E; Kanlayanadonkit R; Keatkla J; Techasaensiri C; Phuphuakrat A; Sungkanuparph S; Apiwattanakul N; Chaisavaneeyakorn S
    J Pediatric Infect Dis Soc; 2021 Feb; 10(1):1-6. PubMed ID: 31981458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appraising the performance of genotyping tools in the prediction of coreceptor tropism in HIV-1 subtype C viruses.
    Crous S; Shrestha RK; Travers SA
    BMC Infect Dis; 2012 Sep; 12():203. PubMed ID: 22938574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monophylogenetic HIV-1C epidemic in Ethiopia is dominated by CCR5-tropic viruses-an analysis of a prospective country-wide cohort.
    Kalu AW; Telele NF; Gebreselasie S; Fekade D; Abdurahman S; Marrone G; Sönnerborg A
    BMC Infect Dis; 2017 Jan; 17(1):37. PubMed ID: 28061826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences.
    Jensen MA; Li FS; van 't Wout AB; Nickle DC; Shriner D; He HX; McLaughlin S; Shankarappa R; Margolick JB; Mullins JI
    J Virol; 2003 Dec; 77(24):13376-88. PubMed ID: 14645592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent CXCR4 tropism of HIV-1 subtype A and CRF02_AG during late-stage disease--indication of an evolving epidemic in West Africa.
    Esbjörnsson J; Månsson F; Martínez-Arias W; Vincic E; Biague AJ; da Silva ZJ; Fenyö EM; Norrgren H; Medstrand P
    Retrovirology; 2010 Mar; 7():23. PubMed ID: 20307309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor.
    Jiang X; Feyertag F; Meehan CJ; McCormack GP; Travers SA; Craig C; Westby M; Lewis M; Robertson DL
    J Virol; 2015 Nov; 89(22):11457-72. PubMed ID: 26339063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy.
    Baroncelli S; Galluzzo CM; Weimer LE; Pirillo MF; Volpe A; Mercuri A; Cavalli A; Fragola V; Monno L; Degli Antoni A; Ladisa N; Francisci D; Bucciardini R; Floridia M
    J Antimicrob Chemother; 2012 Jun; 67(6):1479-85. PubMed ID: 22361986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 co-receptor usage based on V3 loop sequence analysis: preferential suppression of CXCR4 virus post HAART?
    Jiao Y; Wang P; Zhang H; Zhang T; Zhang Y; Zhu H; Wu H
    Immunol Invest; 2011; 40(6):597-613. PubMed ID: 21513481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtype-Dependent Co-receptor Tropism in Cuban HIV-1-Infected Patients: Implications for Maraviroc Treatment.
    Martínez-Montesinos Y; Kourí-Cordellá V; Pérez-Santos L; Han R; Pintos-Saavedra Y; Alemán-Campos Y; Soto-Brito Y; Baños-Morales Y; Caturla-Fernández Y
    MEDICC Rev; 2021; 23(3-4):29-36. PubMed ID: 34516534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selected amino acid changes in HIV-1 subtype-C gp41 are associated with specific gp120(V3) signatures in the regulation of co-receptor usage.
    Dimonte S; Babakir-Mina M; Mercurio F; Di Pinto D; Ceccherini-Silberstein F; Svicher V; Perno CF
    Virus Res; 2012 Sep; 168(1-2):73-83. PubMed ID: 22732432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.